These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9613597)

  • 1. Quantitative analysis of thrombopoietin receptors on human megakaryocytes.
    Kuwaki T; Hagiwara T; Yuki C; Kodama I; Kato T; Miyazaki H
    FEBS Lett; 1998 May; 427(1):46-50. PubMed ID: 9613597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
    Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
    Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.
    Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A
    Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
    Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
    Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human platelets display high-affinity receptors for thrombopoietin.
    Broudy VC; Lin NL; Sabath DF; Papayannopoulou T; Kaushansky K
    Blood; 1997 Mar; 89(6):1896-904. PubMed ID: 9058709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenia in c-mpl-deficient mice.
    Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
    Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.
    Li J; Xia Y; Kuter DJ
    Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
    Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
    Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation.
    Nagahisa H; Nagata Y; Ohnuki T; Osada M; Nagasawa T; Abe T; Todokoro K
    Blood; 1996 Feb; 87(4):1309-16. PubMed ID: 8608219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-mpl, the thrombopoietin receptor.
    Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
    Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analyses of megakaryocytes derived from cord blood and bone marrow.
    Miyazaki R; Ogata H; Iguchi T; Sogo S; Kushida T; Ito T; Inaba M; Ikehara S; Kobayashi Y
    Br J Haematol; 2000 Mar; 108(3):602-9. PubMed ID: 10759720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis.
    Choi ES; Hokom MM; Chen JL; Skrine J; Faust J; Nichol J; Hunt P
    Br J Haematol; 1996 Nov; 95(2):227-33. PubMed ID: 8904874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic effects of thrombopoietin, the Mpl ligand, and its therapeutic potential.
    Papayannopoulou T
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S69-73. PubMed ID: 8765421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
    Li J; Sabath DF; Kuter DJ
    Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
    Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
    Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.
    Broudy VC; Lin NL
    Cytokine; 2004 Jan; 25(2):52-60. PubMed ID: 14693160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin: understanding and manipulating platelet production.
    Kaushansky K
    Annu Rev Med; 1997; 48():1-11. PubMed ID: 9046940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin and the humoral regulation of thrombocytopoiesis.
    Eaton DL; de Sauvage FJ
    Curr Opin Hematol; 1995 May; 2(3):167-71. PubMed ID: 9371990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.